Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2017

Open Access 01-12-2017 | Research article

Anti-inflammatory potential of ellagic acid, gallic acid and punicalagin A&B isolated from Punica granatum

Authors: Lamees A. BenSaad, Kah Hwi Kim, Chin Chew Quah, Wee Ric Kim, Mustafa Shahimi

Published in: BMC Complementary Medicine and Therapies | Issue 1/2017

Login to get access

Abstract

Background

Punica granatum (pomegranate), an edible fruit originating in the Middle East, has been used as a traditional medicine for treatment of pain and inflammatory conditions such as peptic ulcer. The numerous risks associated with nonsteroidal anti-inflammatory drugs (NSAIDs) for treatment of pain and inflammation give rise to using medicinal herbs as alternative therapies. This study aimed to evaluate the anti-inflammatory effect of isolated compounds from the ethyl acetate (EtOAc) fraction of P. granatum by determination of their inhibitory effects on lipopolysaccharide (LPS), stimulated nitric oxide (NO), prostaglandin E2 (PGE-2), interleukin-6 (IL-6) and cyclooxxgenase-2 (COX-2) release from RAW264.7 cells.

Methods

The compounds ellagic acid, gallic acid and punicalagin A&B were isolated from EtOAc by high performance liquid chromatography (HPLC) and further identified by mass spectrometry (MS). The inhibitory effect of ellagic acid, gallic acid and punicalagin A&B were evaluated on the production of LPS-induced NO by Griess reagent, PGE-2 and IL-6 by immunoassay kit and prostaglandin E2 competitive ELISA kit, and COX-2 by Western blotting.

Results

Ellagic acid, gallic acid and punicalagin A&B potentially inhibited LPS-induced NO, PGE-2 and IL-6 production.

Conclusion

The results indicate that ellagic acid, gallic acid and punicalagin may be the compounds responsible for the anti-inflammatory potential of P. granatum.
Literature
1.
go back to reference Gautam R, Jachak SM. Recent developments in antiinflammatory natural products. Med Res Rev. 2009;29(5):767–820.CrossRefPubMed Gautam R, Jachak SM. Recent developments in antiinflammatory natural products. Med Res Rev. 2009;29(5):767–820.CrossRefPubMed
2.
go back to reference Pountos I, Georgouli T, Bird H, Giannoudis PV. Nonsteroidal anti-inflammatory drugs: prostaglandins, indications, and side effects. Int J Interferon Cytokine Mediator Res. 2011;3:19–27.CrossRef Pountos I, Georgouli T, Bird H, Giannoudis PV. Nonsteroidal anti-inflammatory drugs: prostaglandins, indications, and side effects. Int J Interferon Cytokine Mediator Res. 2011;3:19–27.CrossRef
3.
go back to reference Olapour S, Najafzedeh H. Evaluation analgesic, anti-inflammatory and antiepletic effect of hydro alcoholic peel extract of Punica granatum (pomegranate). Asian J Med Sci. 2010;2(6):266–70. Olapour S, Najafzedeh H. Evaluation analgesic, anti-inflammatory and antiepletic effect of hydro alcoholic peel extract of Punica granatum (pomegranate). Asian J Med Sci. 2010;2(6):266–70.
4.
go back to reference Ouachrif A, Khalki H, Chaib S, Muntassir M, Abufatima R, Farouk L, Benharraf A, Chait A. Comparitive study of the anti-inflammatory and antinociceptive effects of two varieties of Punicagranatum. Pharm Biol. 2012;50(4):429–38.CrossRefPubMed Ouachrif A, Khalki H, Chaib S, Muntassir M, Abufatima R, Farouk L, Benharraf A, Chait A. Comparitive study of the anti-inflammatory and antinociceptive effects of two varieties of Punicagranatum. Pharm Biol. 2012;50(4):429–38.CrossRefPubMed
5.
go back to reference Shukla M, Gupta K, Rasheed Z, Khan KA, Haqqi TM. Bioavailable constituents/metabolites of pomegranate (Punica granatum L) prefentially inhibit COX-2activity exvivo and IL-I beta induced PGE2 production in human chondrocytes in vitro. J Inflammation. 2008;5:9.CrossRef Shukla M, Gupta K, Rasheed Z, Khan KA, Haqqi TM. Bioavailable constituents/metabolites of pomegranate (Punica granatum L) prefentially inhibit COX-2activity exvivo and IL-I beta induced PGE2 production in human chondrocytes in vitro. J Inflammation. 2008;5:9.CrossRef
6.
go back to reference Gonzalez-Trujano ME, Pellicer F, Mena P, Monerno DA, Garcia-Viguera C. Antinociceptive and anti-inflammatory activities of a pomegranate (Punica granatum L.) extract rich in ellagitannins. Int J Food Sci Nutr. 2015;66(4):395–9.CrossRefPubMed Gonzalez-Trujano ME, Pellicer F, Mena P, Monerno DA, Garcia-Viguera C. Antinociceptive and anti-inflammatory activities of a pomegranate (Punica granatum L.) extract rich in ellagitannins. Int J Food Sci Nutr. 2015;66(4):395–9.CrossRefPubMed
7.
go back to reference Reddy MK, Gupta SK, Jacob MR, Khan SI, Ferreira D. Antioxidant, antimalarial and antimicrobial activities of tannin-rich fractions, ellagitannins and phenolic acids from Punica granatum L. Planta Med. 2007;73(5):461–7.CrossRefPubMed Reddy MK, Gupta SK, Jacob MR, Khan SI, Ferreira D. Antioxidant, antimalarial and antimicrobial activities of tannin-rich fractions, ellagitannins and phenolic acids from Punica granatum L. Planta Med. 2007;73(5):461–7.CrossRefPubMed
8.
go back to reference Ajaikumar KB, Asheef M, Babu BH, Padikkala J. The inhibition of gastric mucosal injury by Punica granatum L. (Pomegranate) methanolic extract. J Ethnopharmacol. 2005;96:171–6.CrossRefPubMed Ajaikumar KB, Asheef M, Babu BH, Padikkala J. The inhibition of gastric mucosal injury by Punica granatum L. (Pomegranate) methanolic extract. J Ethnopharmacol. 2005;96:171–6.CrossRefPubMed
9.
go back to reference Labib RM, El-Ahmady SH. Antinociceptive, anti-gastric ulcerogenic and anti-inflammatory activities of standardized Egyptian pomegranate peel extract. Journal of Applied Pharmaceutical Science. 2015;5(1):48–51. Labib RM, El-Ahmady SH. Antinociceptive, anti-gastric ulcerogenic and anti-inflammatory activities of standardized Egyptian pomegranate peel extract. Journal of Applied Pharmaceutical Science. 2015;5(1):48–51.
10.
go back to reference Gil MI, Tomas Barberan FA, Hess-Pierce B, Holcroft DM, Kader AA. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem. 2000;48:4581–9.CrossRefPubMed Gil MI, Tomas Barberan FA, Hess-Pierce B, Holcroft DM, Kader AA. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem. 2000;48:4581–9.CrossRefPubMed
11.
go back to reference Lantzourakia DL, Sinanogloub VJ, Zoumpoulakisc P, Proestos C. Comparison of the antioxidant and antiradical activity of pomegranate (Punica granatum L.) by ultrasound-assisted and classical extraction. Anal Lett. 2016;49(7):969–78.CrossRef Lantzourakia DL, Sinanogloub VJ, Zoumpoulakisc P, Proestos C. Comparison of the antioxidant and antiradical activity of pomegranate (Punica granatum L.) by ultrasound-assisted and classical extraction. Anal Lett. 2016;49(7):969–78.CrossRef
12.
go back to reference Jain V, Pareek A, Bhardwaj YR. Attenuating effect of standardized fruit extract of Punica granatum L in rat model of tibial and sural nerve transection induced neuropathic pain. BMC Compl and Alt Med. 2013;13:274.CrossRef Jain V, Pareek A, Bhardwaj YR. Attenuating effect of standardized fruit extract of Punica granatum L in rat model of tibial and sural nerve transection induced neuropathic pain. BMC Compl and Alt Med. 2013;13:274.CrossRef
13.
go back to reference Lansky EP, Newman RA. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol. 2007;109(2):177–206.CrossRefPubMed Lansky EP, Newman RA. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol. 2007;109(2):177–206.CrossRefPubMed
14.
go back to reference Fujihara M, Muroi M, Tanamoto K, Suzuki T, Azuma H, Ikeda H. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide:roles of the receptor complex. Pharmacol Thera. 2003;100(2):171–94.CrossRef Fujihara M, Muroi M, Tanamoto K, Suzuki T, Azuma H, Ikeda H. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide:roles of the receptor complex. Pharmacol Thera. 2003;100(2):171–94.CrossRef
15.
go back to reference Laskin DL, Sunil VR, Gardner CR, Laskin JD. Macrophages and tissue injury:agents of defence or destruction? Annu Rev Pharmacol Toxicol. 2011;51:267–88.CrossRefPubMedPubMedCentral Laskin DL, Sunil VR, Gardner CR, Laskin JD. Macrophages and tissue injury:agents of defence or destruction? Annu Rev Pharmacol Toxicol. 2011;51:267–88.CrossRefPubMedPubMedCentral
16.
go back to reference Kuroda E, Yamashita U. Mechanisms of enchanced macrophage mediated prostaglandin E2 production and its suppressive role in Th1 and Th2 dominant BALB/C mice. J Immunol. 2003;170:757–64.CrossRefPubMed Kuroda E, Yamashita U. Mechanisms of enchanced macrophage mediated prostaglandin E2 production and its suppressive role in Th1 and Th2 dominant BALB/C mice. J Immunol. 2003;170:757–64.CrossRefPubMed
17.
go back to reference Zeihofer HU, Brune K. Analgesic strategies beyond the inhibition of A. Trends Pharmacol Sci. 2006;27:467–74.CrossRef Zeihofer HU, Brune K. Analgesic strategies beyond the inhibition of A. Trends Pharmacol Sci. 2006;27:467–74.CrossRef
18.
go back to reference Jachak SM. PGE synthase inhibitors as an alternative to COX-2 inhibitors. Curr Opin Investig Drugs. 2007;8:411–41.PubMed Jachak SM. PGE synthase inhibitors as an alternative to COX-2 inhibitors. Curr Opin Investig Drugs. 2007;8:411–41.PubMed
19.
go back to reference Ben Saad LA, Kim KH. Phytochemical constituents and analgesic activity of ethyl acetate fraction of Punicagranatum L (Punicaceae). Trop J Pharm Res. 2015;14(1):87–93.CrossRef Ben Saad LA, Kim KH. Phytochemical constituents and analgesic activity of ethyl acetate fraction of Punicagranatum L (Punicaceae). Trop J Pharm Res. 2015;14(1):87–93.CrossRef
20.
go back to reference Lee CJ, Chen LG, Liang WL, Wang CC. Antiinflammatory effects of Punica granatum Linne invitro and invivo. Food Chem. 2010;118(2):315–22.CrossRef Lee CJ, Chen LG, Liang WL, Wang CC. Antiinflammatory effects of Punica granatum Linne invitro and invivo. Food Chem. 2010;118(2):315–22.CrossRef
21.
go back to reference Chun SC, Jee SY, Lee SG, Park SJ, Lee JR, Kim SC. Anti-inflammatory activity of the methanol extract of moutan cortex in LPS-Activated Raw 264.7 Cells. Evid Based Complement Alternat Med. 2007;4(3):327–33.CrossRefPubMed Chun SC, Jee SY, Lee SG, Park SJ, Lee JR, Kim SC. Anti-inflammatory activity of the methanol extract of moutan cortex in LPS-Activated Raw 264.7 Cells. Evid Based Complement Alternat Med. 2007;4(3):327–33.CrossRefPubMed
22.
go back to reference Mena P, Calani L, Dall’Asta C, Galaverna G, García-Viguera C, Bruni R., …Del Rio, D. Rapid and comprehensive evaluation of (Poly) phenolic compounds in pomegranate (Punica granatum L.) juice by UHPLC-MSn. Molecules. 2012;17:14821–40. Mena P, Calani L, Dall’Asta C, Galaverna G, García-Viguera C, Bruni R., …Del Rio, D. Rapid and comprehensive evaluation of (Poly) phenolic compounds in pomegranate (Punica granatum L.) juice by UHPLC-MSn. Molecules. 2012;17:14821–40.
23.
go back to reference Panichayupakaranan P, Tewrakul S, Yuenyongsawad S. Antibacterial anti-inflammatory and antiallergic activities of standardized pomegranate rind extract. Food Chem. 2010;123(2):400–3.CrossRef Panichayupakaranan P, Tewrakul S, Yuenyongsawad S. Antibacterial anti-inflammatory and antiallergic activities of standardized pomegranate rind extract. Food Chem. 2010;123(2):400–3.CrossRef
25.
go back to reference Feldmann M, Brennan D, Chantry C, Haworth M, Turner P, Katsikis M, Londei E, Abney G, Buchan K, Barett A, Corcoran MK, Issonerghis R, Zheng B, Grubeck-Loebenstein D, Barkley CQ, Chu MF, Maini RN. Cytokine assays role in evaluation of the pathogenesis of autoimmunity. Immunol Rev. 1991;119:105–23.CrossRefPubMed Feldmann M, Brennan D, Chantry C, Haworth M, Turner P, Katsikis M, Londei E, Abney G, Buchan K, Barett A, Corcoran MK, Issonerghis R, Zheng B, Grubeck-Loebenstein D, Barkley CQ, Chu MF, Maini RN. Cytokine assays role in evaluation of the pathogenesis of autoimmunity. Immunol Rev. 1991;119:105–23.CrossRefPubMed
27.
go back to reference Sharma JN, Al-Omran A, Parvathy SS. Role of nitric oxide in inflammatory diseases. Inflammopharmacology. 2007;15(6):252–9.CrossRefPubMed Sharma JN, Al-Omran A, Parvathy SS. Role of nitric oxide in inflammatory diseases. Inflammopharmacology. 2007;15(6):252–9.CrossRefPubMed
28.
go back to reference Lowenstein CJ, Alley EW, Raval P, Snowman AM, Syder SH, Russel SW, Murphy WJ. Macrophage nitric oxide synthase gene:Two upstream regions mediate induction by interferon V and lipopolysaccaride. Proc Natl Acad Sci. 1993;90:9730–5.CrossRefPubMedPubMedCentral Lowenstein CJ, Alley EW, Raval P, Snowman AM, Syder SH, Russel SW, Murphy WJ. Macrophage nitric oxide synthase gene:Two upstream regions mediate induction by interferon V and lipopolysaccaride. Proc Natl Acad Sci. 1993;90:9730–5.CrossRefPubMedPubMedCentral
29.
go back to reference Kim AR, Cho JY, Zou Y, Choi JS, Chung HY. Flavonoids differentially modulate nitric oxide production pathways in lipopolysaccharide-activated RAW264.7 cells. Arch Pharm Res. 2005;28:297–304.CrossRefPubMed Kim AR, Cho JY, Zou Y, Choi JS, Chung HY. Flavonoids differentially modulate nitric oxide production pathways in lipopolysaccharide-activated RAW264.7 cells. Arch Pharm Res. 2005;28:297–304.CrossRefPubMed
30.
go back to reference Xu X, Yin P, Wan C, Chong X, Liu M, Cheng P, Chen J, Liu F, Xu J. Punicalagin inhibits inflammation in LPS-induced RAW264.7 macrophages via the suppression of TLR4-mediated MAPKs and NF-κB activation. Inflammation. 2014;37(3):956–65.CrossRefPubMed Xu X, Yin P, Wan C, Chong X, Liu M, Cheng P, Chen J, Liu F, Xu J. Punicalagin inhibits inflammation in LPS-induced RAW264.7 macrophages via the suppression of TLR4-mediated MAPKs and NF-κB activation. Inflammation. 2014;37(3):956–65.CrossRefPubMed
31.
go back to reference Olajide OA, Kumar A, Velagapudi R, Okorji UP, Fiebich BL. Punicalagin inhibits neuroinflammation in LPS-activated rat primary microglia. Mol Nutr Food Res. 2014;58(9):1843–51.CrossRefPubMed Olajide OA, Kumar A, Velagapudi R, Okorji UP, Fiebich BL. Punicalagin inhibits neuroinflammation in LPS-activated rat primary microglia. Mol Nutr Food Res. 2014;58(9):1843–51.CrossRefPubMed
32.
go back to reference Gabby C. Interleukin-6 and chronic inflammation. Arthritis Res Ther. 2006;8 Suppl 2:S3.CrossRef Gabby C. Interleukin-6 and chronic inflammation. Arthritis Res Ther. 2006;8 Suppl 2:S3.CrossRef
33.
go back to reference Huangi GJ, Huangi MH, CHI CS, Huangi S, Shie PH, Yen MT, Wang BS. Analgesic and anti-inflammatory activities of aqueous extracts of Fructus ligustri lucidi. J Food Drug Anal. 2012;20(3):617–27. Huangi GJ, Huangi MH, CHI CS, Huangi S, Shie PH, Yen MT, Wang BS. Analgesic and anti-inflammatory activities of aqueous extracts of Fructus ligustri lucidi. J Food Drug Anal. 2012;20(3):617–27.
34.
go back to reference Karlsson S, Nåmberg E, Fjaeraa C, Wijkander J. Ellagic acid inhibits lipopolysaccharide-induced expression of enzymes involved in the synthesis of prostaglandin E2 in human monocytes. Br J Nutr. 2010;103:1102–9.PubMed Karlsson S, Nåmberg E, Fjaeraa C, Wijkander J. Ellagic acid inhibits lipopolysaccharide-induced expression of enzymes involved in the synthesis of prostaglandin E2 in human monocytes. Br J Nutr. 2010;103:1102–9.PubMed
Metadata
Title
Anti-inflammatory potential of ellagic acid, gallic acid and punicalagin A&B isolated from Punica granatum
Authors
Lamees A. BenSaad
Kah Hwi Kim
Chin Chew Quah
Wee Ric Kim
Mustafa Shahimi
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2017
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-017-1555-0

Other articles of this Issue 1/2017

BMC Complementary Medicine and Therapies 1/2017 Go to the issue